I have years of experience in Cancer research, in these years I have opportunity for serious involvement in important national projects. In Addition to my research background I have excellent Experience in Team management and leadership, Strategic planning and problem solving.
- 2005 Top second in Iranian Biology Olympiad
- 2006 Rank 156 national university entrance exam
- 2014 Medical Doctorates – Shahid Beheshty University of Medical Science
- 2018 Radiation Oncology Resident Tehran University of medical Science
- 2018 Ph.D by Research Student ,Clinical Cancer Epidemiology, Cancer Institute of Iran
- 2006-2017: Members of National Talents organization (Bonyad Melli Nokhbeghan)
- 2008-2012: National Committee of Medical Research Ethics; Development of National Regulatory in Research Misconduct
- 2008-2017: Research Position in Cancer Research Center of Cancer Institute of Iran
- 2014-2016: Research Position in AJA Cancer Research Cancer –Aja university of Medical Science (as my” Military Service “duty )
- 2016-2017: Research manager in Clinical Cancer Research Center Milad Hospital
|
Clinical / Epidemiological Study through
|
|
System Design & Strategic Planning
|
|
Team Building and Empowerment
|
|
Project Management
|
| National procedure for investigating the research misconduct | Implementation
|
| National Cancer Support & Palliative Care program | Website design and developmen |
- Developing and Implementation of National Guideline for Trastuzumab (Herceptin) in Breast Cancer Patients , 2010-2011;
- Developing of Patient Guide on Using Trastuzumab –2010;
- Adaptation of Breast Cancer Patients electronic Information management system with National Trastuzumab guideline-2010-2011;
- Developing and Implementation of National Regulation on Investigation of Research Misconduct in Medical Research- 2008-2011;
- Development and Implementation of National Hospital Cancer Registry ( Cancer Institue of Iran and Milad hospital)
- Developing “National Cancer Support & Palliative Care program”- 2011-2013;
- Determination of Research Priorities for AJA University of Medical Science.2014-2016
- Development of National brachytherapy guideline 2019
- Development and implementation of national Cilinical breast cancer registry 2019
- Development of COVID19 prevention & care; a cancer specific guideline
- Development of National Cervical cancer brachytherapy guideline
- Gastric Cancer Patients Survival ,in Baghiatallah hospital-Analysis of 15 year of Data-2010;
- Gastric cancer Patients Survival ,in Baghiatallah ,Milad and Cancer Institute of Iran- Prospective and multicenter study-2009-2014;
- Lymph Nodes Assessment After Gastrectomy in Gastric Cancer Patients in Baghiatallah-Milad and Institute Cancer of Iran- Prospective and multicenter study-2009-2014;
- Professional delay in diagnosis of Oral cancer in Iran 2012-2014;
- Esophagus cancer survival and its prognostic factors between patients treated in Institute2011-2013;
- Glioblastoma tumors prognostic factor and Survival analysis
- Mir MR, Rajabpour MV, Delarestaghi MM, Hadji M, Harirchi I, Mir P, Mir A, Lashkari M, Zendehdel K,Short- and long-term survival of esophageal cancer patients treated at the Cancer Institute of Iran. Dig Surg. 2013;30(4-6):331-6. doi: 10.1159/000354854. Epub 2013 Sep 17.
- Khedmat H, Panahian M, Mashahdian M, Rajabpour MV, Zendehdel K, Prognostic factors and survival in stomach cancer – analysis of 15 years of data from a referral hospital in Iran and evaluation of international variation. Onkologie. 2011;34(4):178-82
- Farhad Esmaelbeigi MD, Maryam Hadji MSc, Iraj Harirchi MD, Ramesh Omranipour MD, Mojtaba vand Rajabpour MD, Kazem Zendehdel PhD, Factors Affecting Professional Delay in Diagnosis and Treatment of Oral Cancer in Iran, Archives of Iranian Medicine,Vol. 17, No. 04, April 2014
- Vand Rajabpour M, Yahyazadeh H, Beheshti M. Prognostic Factors and Survival of Glioblastoma Multiform (GBM) in Iranian Patients, Int J Cancer Manag. 2017 ;10(4):e6260.
- Rouhollahi MR , Mohammad Nejad S , Harirchi I , Zarei B , Keshtmand G , Sedighi S , Rajabpour MV et al . Policy Brief Management of Herceptin (Trastuzumab) in Patients with Breast Cancer in Iran: Procurement, Allocation, Patient Eligibility Criteria, Prescription and Financial Protection. Hakim. 2013; 15 (4) :270-280
- Mojtaba Vand Rajabpour, Elena Ghotbi, Bahram Salmanian, Sepideh Azizi, Hossein Yahyazadeh, Hossein Khedmat, Afshin Abdirad, Iraj Harichi , Kazem Zendehdel
Lymph Nodes Assessment After Gastrectomy in Gastric Cancer Patients (under Review and Submission) - zendehdel k, Rajabpour MV, et al , Trastuzumab Effectiveness in Breast Cancer patients, Trastuzumab Guideline in Breast Cancer ,Pajoheshgharan Nashr Daneshgahi,Teharn , 2011, p83-109 (Farsi)
- zendedel k, Motlag AG, Homaii F, Rajabpour MV, Estimating the prevalence of the Breast Cancer patients Needs Trastuzumab , Trastuzumab Guideline in Breast Cancer ,Pajoheshgharan Nashr Daneshgahi,Teharn , 2011, p117-133(Farsi)
- Rohollahi M, Rajabpour MV, Adaptation of Breast Cancer Patients electronic Information management system with National Trastuzumab guideline, Trastuzumab Guideline in Breast Cancer ,Pajoheshgharan Nashr Daneshgahi,Teharn , 2011, p201-219 (Farsi)
- Motlagh, Ali, Maisa Yamrali, Samira Azghandi, Payam Azadeh, Mohammad Vaezi, Farzaneh Ashrafi, Kazem Zendehdel et al. “COVID19 prevention & care; a cancer specific guideline.” Archives of Iranian medicine 23, no. 4 (2020): 255-264.
- Aghili, Mahdi, Fatemeh Jafari, and Mojtaba Vand Rajabpoor. “Brachytherapy during the coronavirus disease 2019–Lessons from Iran.” Brachytherapy 19.4 (2020): 412-414.
- MS office
- Microsoft Visio –flowchart software
- Stata, SPSS-Statical software
1-persian
2-English
- Cancer epidemiology, treatment and control
- Cancer molecular and genetic studies
- Cancer regitery and Information Technology
- Personalized Medicine and Translational Research